Results 291 to 296 of about 35,120,764 (296)

Use of the 22C3 anti–programmed death-ligand 1 antibody to determine programmed death-ligand 1 expression in cytology samples obtained from non–small cell lung cancer patients

Cancer Cytopathology, 2018
Marius Ilié, Paul Hofman, Lingkang Huang   +2 more
exaly  

Prognostic implication of programmed cell death 1 protein and its ligand expressions in endometrial cancer

Gynecologic Oncology, 2018
Hye Sun Lee, Jea Hoon Kim, Doo Byung Chay   +2 more
exaly  

Exploring the role of programmed cell death protein 1 and its ligand 1 in eye diseases

Critical Reviews in Clinical Laboratory Sciences, 2019
Yunshan Cao, Xiu Wang, Xiao-Rong Li
exaly  

Clinical Significance of Programmed Death-1 Ligand-1 Expression in Patients with Non-Small Cell Lung Cancer: A 5-year-follow-up Study

Tumori, 2012
exaly  

Bevacizumab/programmed cell death-1-ligand-1-inhibitors

Reactions Weekly
openaire   +1 more source

[Programmed death-1/programmed death-ligand 1 pathway and T cell exhaustion in sepsis].

Zhonghua nei ke za zhi
J Y, Zhang, Y, Yang, L, Liu
openaire   +1 more source